Biochemical Competition Makes Fatty-Acid beta-Oxidation Vulnerable to Substrate Overload by van Eunen, Karen et al.
  
 University of Groningen
Biochemical Competition Makes Fatty-Acid beta-Oxidation Vulnerable to Substrate Overload
van Eunen, Karen; Simons, Sereh M. J.; Gerding, Albert; Bleeker, Aycha; den Besten, Gijs;





IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2013
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
van Eunen, K., Simons, S. M. J., Gerding, A., Bleeker, A., den Besten, G., Touw, C. M. L., ... Bakker, B. M.
(2013). Biochemical Competition Makes Fatty-Acid beta-Oxidation Vulnerable to Substrate Overload. PLoS
Computational Biology, 9(8), [1003186]. https://doi.org/10.1371/journal.pcbi.1003186
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
Biochemical Competition Makes Fatty-Acid b-Oxidation
Vulnerable to Substrate Overload
Karen van Eunen1,2, Sereh M. J. Simons1, Albert Gerding1,3, Aycha Bleeker1, Gijs den Besten1,2,
Catharina M. L. Touw1, Sander M. Houten4, Bert K. Groen1,2, Klaas Krab5, Dirk-Jan Reijngoud1,2,3,
Barbara M. Bakker1,2*
1Department of Pediatrics, Center for Liver, Digestive and Metabolic Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands,
2Netherlands Consortium for Systems Biology, Amsterdam, The Netherlands, 3Department of Laboratory Medicine, Center for Liver, Digestive and Metabolic Diseases,
University of Groningen, University Medical Center Groningen, Groningen, The Netherlands, 4 Laboratory Genetic Metabolic Diseases, Departments of Clinical Chemistry
and Pediatrics, Emma Children’s Hospital, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands, 5Department of Molecular Cell Physiology,
Netherlands Institute for Systems Biology, VU University Amsterdam, Amsterdam, The Netherlands
Abstract
Fatty-acid metabolism plays a key role in acquired and inborn metabolic diseases. To obtain insight into the network
dynamics of fatty-acid b-oxidation, we constructed a detailed computational model of the pathway and subjected it to a fat
overload condition. The model contains reversible and saturable enzyme-kinetic equations and experimentally determined
parameters for rat-liver enzymes. It was validated by adding palmitoyl CoA or palmitoyl carnitine to isolated rat-liver
mitochondria: without refitting of measured parameters, the model correctly predicted the b-oxidation flux as well as the
time profiles of most acyl-carnitine concentrations. Subsequently, we simulated the condition of obesity by increasing the
palmitoyl-CoA concentration. At a high concentration of palmitoyl CoA the b-oxidation became overloaded: the flux
dropped and metabolites accumulated. This behavior originated from the competition between acyl CoAs of different chain
lengths for a set of acyl-CoA dehydrogenases with overlapping substrate specificity. This effectively induced competitive
feedforward inhibition and thereby led to accumulation of CoA-ester intermediates and depletion of free CoA (CoASH). The
mitochondrial [NAD+]/[NADH] ratio modulated the sensitivity to substrate overload, revealing a tight interplay between
regulation of b-oxidation and mitochondrial respiration.
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Introduction
Pathophysiological mechanisms underlying acquired and in-
born metabolic diseases, such as type-2 diabetes and deficiencies in
the fatty-acid oxidation, are largely elusive. Although we know
many important molecular factors, yet the complexity of the
metabolic and regulatory network hampers elucidating the rela-
tion between the primary disease factors and their systemic effects
[1,2]. Moreover, the experimental accessibility of large parts of the
metabolic networks is limited. Computational kinetic models yield
insight into the dynamics of metabolic networks and make
predictions about the parts that are experimentally inaccessible.
Fatty-acid (FA) b-oxidation is a prime example of a pathway
involved in many diseases, but for which it is difficult to acquire a
complete and quantitative view on the relation between metabolite
concentrations and fluxes. Insulin resistance, one of the hallmarks
of metabolic syndrome, is strongly associated with elevated levels
of free FAs [3]. It has been argued that an imbalance between
cellular FA uptake and oxidation leads to accumulation of FAs and
other lipid molecules in the cytosol, which in turn causes insulin
resistance [4,5]. Others showed that a functioning acyl-CoA
uptake into mitochondria is needed to develop insulin resistance,
leading to the hypothesis that intermediates of FA b-oxidation are
part of the problem [6]. Since the acyl-CoA intermediates are
difficult to measure, conclusions are often based on acyl-carnitine
levels in the blood [7,8], which are interpreted as a reflection of
acyl-CoA concentrations in the mitochondria. Similar limitations
hamper the understanding of systemic effects of enzyme deficien-
cies in the FA b-oxidation and their impact on global energy and
glucose regulation [9,10]. Clearly, a more direct view on the
dynamics of b-oxidation intermediates is urgently needed.
A careful look at the basic biochemistry of the FA b-oxidation
reveals complex interactions, of which the implications have never
been investigated (Figure 1). First, it is a cyclic pathway. In each
cycle the acyl-CoA substrate is shortened by two carbon atoms and
the product is a substrate for the next cycle. Second, the shortened
acyl-CoA product competes with the substrate for a set of enzymes
with overlapping chain-length specificity. The complete break-
down of palmitoyl CoA, an acyl CoA with 16 carbon atoms, to 8
molecules of acetyl CoA (C2) requires seven reaction cycles. There
are, however, only four acyl-CoA dehydrogenases and two parallel
sets of enzymes for the further conversion of enoyl CoA (Figure 1).
This results in a competition in two ways: substrates of different
chain lengths compete for common enzymes, while enzymes with
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overlapping specificity compete for common substrates. The
competition between substrates generates a feedforward inhibition
in the network: the more palmitoyl CoA molecules enters the
pathway, the more enzyme molecules they occupy, which are then
not available for shorter acyl CoAs downstream in the pathway.
Third, the two parallel pathways for the breakdown of enoyl-CoA
molecules are of a different nature. Enoyl CoAs are either
converted by a sequence of three enzymes (crotonase, medium/
short-chain hydroxyacyl-CoA dehydrogenase (M/SCHAD) and
medium-chain ketoacyl-CoA thiolase (MCKAT)) or via the
mitochondrial trifunctional protein (MTP), which catalyzes the
entire sequence of reactions (Figure 1). At present it is unclear how
these properties affect the pathway behavior.
In contrast to the myriad of models of carbohydrate metabo-
lism, we know of only two kinetic models of FA b-oxidation and
each of these ignores the above biochemical interactions. The first
model [11] contains only a single cycle of b-oxidation and thereby
lacks the competition between the pathway substrate and its
downstream products. The second model does comprise the com-
plete conversion of acyl CoAs to acetyl CoA, but the authors
overlooked that this should lead to competition and modeled it as
if distinct pools of each enzyme existed for each substrate [12].
In this study we present and validate a quantitative kinetic model
of the mitochondrial FA b-oxidation, which explicitly includes
molecular competition. This model reveals how the complex
biochemical wiring of the network gives rise to non-intuitive or
Author Summary
Lipid metabolism plays an important role in the develop-
ment of metabolic syndrome, a major risk factor for
cardiovascular disease and diabetes. Furthermore, inborn
errors in lipid oxidation cause rare, but severe diseases in
children. To obtain more insight into the response of lipid
oxidation to dietary and medical interventions, we con-
structed a computational model. The model correctly
simulated the rate of lipid oxidation and the time courses
of most acyl carnitines. The latter are used as diagnostic
markers in blood. Subsequently, we subjected the model
to an increased supply of lipids, as often happens in obese
people. We discovered that the lipid-oxidation machinery
easily becomes overloaded, very much like a highway
during rush hours: the more cars enter the road, the slower
they proceed and the more they clog the road. Analo-
gously, an overload of lipids slowed down the lipid
oxidation and led to an accumulation of intermediate
metabolites in the pathway. Potential protection mecha-
nisms of cells consist of restricted entry of lipids into the
oxidation pathway or efficient downstream processing of
reaction products. In future research we will use the model
to test dietary or medical interventions in silico and
thereby guide the development of new treatment and
prevention strategies.
Figure 1. Schematic overview of FA b-oxidation as it is modeled in this study. Enzymes are depicted in italics bold face, metabolites in
regular and allosteric inhibitors in red. CPT1: carnitine-palmitoyl transferase 1 (E.C. 2.3.1.21), CACT: carnitine-acyl-carnitine translocase, CPT2: carnitine-
palmitoyl transferase 2 (E.C. 2.3.1.21), VLCAD: very-long-chain acyl-CoA dehydrogenase (E.C. 1.3.99.3), LCAD: long-chain acyl-CoA dehydrogenase (E.C.
1.3.99.3), MCAD: medium-chain acyl-CoA dehydrogenase (E.C. 1.3.99.3), SCAD short-chain acyl-CoA dehydrogenase (E.C.1.3.8.1 for butanoyl CoA (C4)
(was previously E.C. 1.3.99.2) and E.C. 1.3.99.3 for hexanoyl CoA (C6)), MTP: mitochondrial trifunctional protein (E.C. 4.2.1.17, E.C. 1.1.1.211 and E.C.
2.3.1.16), M/SCHAD: medium/short-chain hydroxyacyl-CoA dehydrogenase (E.C. 1.1.1.35), MCKAT: medium-chain ketoacyl-CoA thiolase (E.C. 2.3.1.16).
The chain-length specificity as included in the model is indicated for each enzyme (e.g. C6–C12). The boundary metabolites which are kept at fixed
concentrations are underlined. The direction of the flux is from the small to large arrow heads.
doi:10.1371/journal.pcbi.1003186.g001
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‘emergent’ behavior [13]. We will show i) how the competition
renders the pathway vulnerable to substrate overload; ii) how the
robustness of the system can be modulated; and iii) what the role is
of the experimentally inaccessible CoA esters in this process.
Results
Model construction
We constructed a model for mitochondrial FA b-oxidation with
all enzyme reactions and transporters (Figure 1). The reactions
correspond to the mitochondrial b-oxidation module in the
updated human metabolic reconstruction [14], with the difference
that we tailored them to rat liver. Thus, we added the long-chain
acyl-CoA dehydrogenase (LCAD), which is involved in rodent b-
oxidation [15–18]. The model is limited to the b-oxidation of
saturated FAs containing an even number of carbon atoms. It
starts from the transport of palmitoyl CoA across the mitochon-
drial inner membrane by the carnitine shuttle. The shuttle is
reversible and also catalyzes the export of acyl-CoA esters of other
chain lengths, which can be released as acyl carnitines in the
extramitochondrial space. For simplicity we assumed that CPT1
activity is restricted to palmitoyl CoA (C16). Once inside the
mitochondrial matrix, acyl-CoA molecules are oxidized to enoyl
CoA by a set of chain-length-specific, FAD-dependent acyl-CoA
dehydrogenases (SCAD, MCAD, LCAD and VLCAD in Figure 1)
[15,17]. The resulting enoyl CoAs undergo a sequential hydratase,
dehydrogenase and thiolase reaction, leading to the formation of
an NADH, an acetyl CoA and an acyl CoA which is two C-atoms
shorter than the substrate of the cycle. This sequence of reactions
is either catalyzed by the MTP (the right-hand branch in Figure 1)
[19] or by three different enzymes (the left hand ‘crotonase’
branch in Figure 1) [20–25]. We assume that MTP does not
release the hydroxyacyl-CoA and ketoacyl-CoA intermediates in
the matrix, but channels them from one active site to another. In
contrast, the intermediates in the ‘crotonase’ branch can diffuse
freely through the matrix. There is overlap between the substrates
that can be converted by the two pathways. However, MTP has a
preference for longer chain lengths, while C4 and C6 substrates
are uniquely converted by the crotonase branch.
The reaction scheme in Figure 1 is translated into a set of 45
ODEs describing how the time derivatives of the concentrations of







denotes that the rate of change of the enoyl-CoA concentration of
chain length C14 in the mitochondrial matrix equals the rate v of
formation by VLCAD and LCAD minus the rate of consumption
by crotonase and MTP. VMAT denotes the volume of the mito-
chondrial matrix. In equation 1 each reaction rate is specific for a
certain combination of enzyme and substrate, since most enzymes
catalyze multiple reactions. The competing substrates inhibit each
other’s conversion competitively. This leads for instance to the

























In the above ODE (equation 1) n= 14 for conversion of C14
and therefore the parameters for C14 are filled in, except in the S-
term which sums over all substrates and products that are
converted by crotonase and thus bind the enzyme reversibly. All of
the reactions are modeled as reversible, mostly of Michaelis-
Menten type as above, and most parameters were taken from the
literature and mainly based on biochemical characterization of
purified rat-liver enzymes. Some affinity and equilibrium constants
were taken from rat-heart datasets. However, for enzymes of
which only one isoenzyme exists, the affinity constants may be
considered to be tissue-independent. Equilibrium constants do not
depend at all on the enzyme that catalyzes the reaction. Three
parameters, Vcpt1, Vvlcad and Vlcad, were estimated, since we could
not find a reliable value in literature.
Three conserved moieties follow from the pathway stoichiom-
etry: the total of FAD, NAD+ and CoA species. The model fulfills
the criterion of microscopic reversibility, i.e. alternative reaction
paths have the same overall equilibrium constant. For instance, the
overall equilibrium constant of the MTP reaction equals the
product of the equilibrium constants in the crotonase branch. We
note that most equilibrium constants are not far from 1; hence
the pathway lacks a strong thermodynamic driving force
and depends on the delivery of substrate upstream and the
further conversion of products downstream. A notable exception is
the couple M/SCHAD – MCKAT, which has equilibrium
constants of respectively 2.2?1024 and 1.1?103. This implies that
M/SCHAD favors the reverse direction, which is compensated by
the high equilibrium constant of MCKAT. MTP dampens this
thermodynamic hurdle by keeping the intermediate ketoacyl CoA
bound.
Based on the above principles, we constructed a model of 45
variable metabolite concentrations, 56 reactions and 234 param-
eters (for detailed description see Text S1), which predicts fluxes
and metabolites in time and at steady state.
Experimental validation of the model
The predicted model outcome was validated with experiments
on isolated rat-liver mitochondria. We measured the oxygen-
consumption flux and the acyl-carnitine concentrations (C4–C16)
in time upon addition of palmitoyl CoA or palmitoyl carnitine.
Mitochondria were incubated with an excess amount of malate.
In this way CoASH could be regenerated from acetyl CoA by
malate dehydrogenase and citrate synthase, allowing the b-
oxidation to proceed. Each cycle of b-oxidation in the presence of
excess malate gives rise to 1 FADH2 by acyl-CoA dehydrogenase
and 2 NADH by enoyl-CoA dehydrogenase and malate dehydro-
genase. The oxygen flux due to the b-oxidation per se was obtained
by correcting the measured oxygen consumption for the oxygen
consumption due to malate dehydrogenase. That malate to citrate
was the main source of NADH beyond the b-oxidation was
confirmed by measuring citrate, which indeed accumulated over
time. Over the entire time course of 24 min, there was no significant
gap between the carbon consumed as palmitoyl carnitine and the
recovered products: carbon consumed=216 N ([acyl carnitineC16]t24 -
[acyl carnitineC16]t0) = 328 6 89 mM(SD) and carbon produced





: ½acylcarnitineC 2nt 24{

½acylcarnitineC 2nt 0Þ~196+103 mM (SD); paired t-test p.0.05.
Note that we did not include the carnitine moiety in the balance as it
plays only a catalytic role. The same holds for the four carbons in
citrate that are derived from malate. a-Ketoglutarate was not
detectable. The uncertainty of the carbon balance leaves, however,
room for other intermediates to contribute.
We determined the time course of palmitoyl carnitine and used
this as an input function for the substrate concentration in the
Kinetic Modeling of Fatty-Acid Beta-Oxidation
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model. We assumed that the time course was similar for palmitoyl
CoA when the latter was given as substrate (see Text S1).
Within the experimental error the experimental and modeled
flux corresponded well on both substrates (Figure 2A and Figure
S1A). With palmitoyl carnitine, but not with palmitoyl CoA, a
sharp initial overshoot was observed in the oxygen consumption
flux, which was reproduced qualitatively by the model (Figure
S1D–G). For the experiment with palmitoyl CoA as substrate, the
dynamics of palmitoyl carnitine and the downstream intermediates
myristoyl, octanoyl and hexanoyl carnitine (C14, C8 and C6) were
quantitatively reproduced by the model. The remaining acyl
carnitines (C10–C12 and C4) showed a qualitative correspondence
between the experiment and model (Figure 2 and Figure S2A): the
dynamics of the acyl carnitines were in all cases in the same
direction, but the concentrations and/or timescale differed. For
the experiment with palmitoyl carnitine as substrate, a qualitative
correspondence was found, but the timescale and also concentra-
tions differed (Figure S1B–C and S2B). We emphasize that the
model parameters were not fitted to the experiments hence the
correspondence betweenmodel and experiment is remarkably good.
Perturbation of the system: Mimicking obesity
FA levels in plasma from obese people are often elevated [3,8].
This means a constantly high availability of FAs for the b-
oxidation. We have simulated this by calculating the steady-state
flux and metabolite concentrations as a function of the concen-
tration of palmitoyl CoA, the substrate in the model (Figure 3).
The flux increased with an increasing concentration of palmitoyl
CoA, but above 50 mM the flux decreased steeply, yet smoothly
(Figure 3A, standard model). This was preceded by an accumu-
lation of CoA esters (Figure 3B and Figure S3E) and consequently
a decrease of CoASH (Figure 3B, standard model).
Most often a metabolic flux reaches a maximum at saturating
substrate concentration, hence we considered the steep decline at
high palmitoyl CoA an emergent, non-intuitive property of the b-
oxidation. To prove that this property resulted from the compe-
tition between metabolites for a common set of enzymes, we
adapted the model such that a percentage of each enzyme was
dedicated to a particular chain length (‘No competition’ in
Figure 3). This percentage was attributed such that at 25 mM of
palmitoyl CoA the flux distribution among parallel enzymes was
similar in both models (Figure S4). Indeed, in the model without
competition the flux increased until saturation (Figure 3A), while
the accumulation of CoA esters and the depletion of CoASH were
prevented (Figure S3F and 3B).
A priori either the accumulation of the CoA esters or the
depletion of CoASH could cause the decline of flux in the standard
model. To distinguish between these possibilities we fixed the
CoASH concentration in the standard model and left the CoA
esters free to accumulate (Figure 3B), i.e. as if an external supply of
CoASH had broken the moiety conservation. In this scenario the
CoA esters accumulated extremely (Figure 3B and Figure S3G),
but the flux nevertheless increased until saturation (Figure 3A,
fixed CoASH). Accordingly, the drop in flux observed in the
standard model is a result of CoASH depletion rather than of the
high CoA-ester concentration.
Sensitivity analysis revealed that the influx of FAs into the FA b-
oxidation by CPT1 and the consumption of the products of the
enzyme M/SCHAD (NADH and ketoacyl CoAs in the mitochon-
drial matrix) had the largest effect on the CoASH concentration
(Table S1). To explore the role of CPT1, we decreased its activity by
adding the endogenous CPT1 inhibitor malonyl CoA or by lowering
its Vmax. At low concentrations of palmitoyl CoA the flux was lower
than in the standard model, but it rose to the samemaximum and the
drop in flux occurred at a higher palmitoyl-CoA concentration
(Figure 3A and S3A). Accordingly, the accumulation of CoA esters
and the depletion of CoASH still occurred, but at higher concen-
trations of palmitoyl CoA (Figure 3B and S3B, S3H–I). The influence
of M/SCHAD is due to its very small equilibrium constant (2 ? 1024
[11,26]) implying that the reaction can only work in the direction of
the b-oxidation when its product concentrations are extremely low as
compared to its substrate concentrations. To shift the M/SCHAD
reaction in the forward direction, we increased the NAD/NADH
ratio in the mitochondrial matrix from 15 to 40 without altering the
Figure 2. Comparison between the model simulations and the experiment with palmitoyl CoA as substrate. At time point zero the
substrate palmitoyl CoA was added to uncoupled mitochondria in the presence of an excess amount of L-carnitine and malic acid. Samples for acyl
carnitine analysis were taken at different time points. Error bars on the experimental data represent SEM (n= 4 for the flux data, n = 8 for the acyl-
carnitine concentrations). Panel A: Comparison of the experimental and modeled flux through the FA b-oxidation. The reported experimental flux is
2/3 of the oxygen consumption flux averaged from 1.5 to 8 min. The modeled flux equals the production fluxes of NADH plus FADH2 divided by 2
(one O2 oxidizes two NADH or FADH2), averaged over the same time interval. Panel B: experimental acyl-carnitine concentrations in total samples, i.e.
including intra- and extramitochondrial metabolites. Panel C: acyl-carnitine concentrations simulated by the computer model, representing the
weighted average over the matrix and extramitochondrial concentrations to allow direct comparison to the experiments.
doi:10.1371/journal.pcbi.1003186.g002
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sum of NAD and NADH. This prevented the flux decline at higher
palmitoyl-CoA concentrations (Figure 3C and S3C). Accordingly, the
concentrations of the CoA esters stayed low (Figure S3J) and a high
CoASH concentration was maintained (Figure S3D).
Discussion
In this paper we present the first dynamic model of the FA b-
oxidation that appreciates the complex biochemical interactions in
the network. Notably, we included the extensive competition in
the system, as well as the qualitatively different pathways for con-
version of enoyl CoAs. The parameters were based on biochemical
analysis of individual enzymes and not fitted to obtain the desired
metabolite and flux profiles. In this light, the correspondence
betweenmodel predictions and experimental observations (Figure 2)
was remarkably good. This allowed us to further explore the pro-
perties of the pathway.
We found that the unique pathway structure makes the FA b-
oxidation vulnerable to substrate overload: at high palmitoyl-CoA
concentrations the shorter CoA esters accumulate to outcompete
the palmitoyl CoA. Above a critical palmitoyl-CoA concentration
this results in depletion of CoASH and a steep decline in flux.
This is an example of an ‘emergent’ property: it would not have
occurred in a linear pathway without competition. Hence, it
could not be predicted from the properties of the individual
enzymes, but resulted from the wiring of the entire network. It is
tempting to speculate that this overload phenotype is at the basis
of various diseases and may be one of the mechanisms of
lipotoxicity. We emphasize, however, that we modeled the FA b-
oxidation in isolation. In reality, surrounding pathways may
protect the pathway from overload. In addition, the model
revealed two possible protection mechanisms at the pathway
boundaries. In the following we will discuss these protective
mechanisms as well the possible role of fatty-acid overload in
insulin resistance.
First, according to the model the flux decline could be prevented
by decreasing the activity of CPT1. Accordingly, increased
concentrations of the CPT1 inhibitor malonyl CoA as well as a
decreased catalytic capacity of CPT1 have been observed
experimentally [27–32]. The most convincing data are for malonyl
CoA, which is increased in skeletal muscle of obese humans and
rodents [27,28,31,32] as well as in liver tissue from obese mice
[27]. Instead of being a cause of obesity via decreased FA oxidation
and increased synthesis, malonyl CoA may rather confer protection
against overload of the b-oxidation.
A second mechanism to prevent overload was to keep the
products of the thermodynamically unfavorable M/SCHAD
reaction low. In the parallel MTP pathway the long-chain
hydroxyacyl-CoA (LCHAD) dehydrogenase is linked to the
preceding long-chain enoyl-CoA hydratase and the following
long-chain ketoacyl-CoA thiolase at the inner mitochondrial
membrane [19,23,33]. Since the intermediate CoA esters are
not detectable, it has been proposed that they are directly
channeled from one active site to another [19,23,33–37]. The
overall equilibrium constant of the lumped MTP reaction is 0.7,
dampening the thermodynamic hurdle at LCHAD. Channeling
has not been described for the short-chain intermediates (C4 and
C6) and therefore we modeled their conversion by a sequence of
enzymes (the ‘crotonase branch’) including the M/SCHAD
reaction. The impact of the thermodynamic hurdle at M/SCHAD
is demonstrated by the fact that the long-chain intermediates have
a strong preference for the MTP branch, even though they could
in principle be converted by the crotonase branch (Figure S4).
Only C4 and C6 substrates, which are not recognized by MTP,
take the crotonase route. Due to the low equilibrium constant of
M/SCHAD (Keq=2610
24), the C6 and C4 intermediates
Figure 3. Steady-state fluxes and concentration of the intermediate metabolite at various concentrations of the substrate palmitoyl
CoA. Panels A and C: Steady-state flux through the FA b-oxidation. Panel B: CoASH concentration (solid lines) and total CoA esters (dashed lines)
corresponding to the simulations in A. Panel D: Graphical representation of the differences between the computational models with and without
competition. Blue lines in A and B: standard model; red lines in A and B: model without competition; green lines in A and B: model with fixed CoASH
concentration (see text). Solid line in C: standard model (malonyl-CoA concentration 0 mM, mitochondrial NAD/NADH ratio 15); short-dashed line in C:
standard model but with increased concentration of malonyl CoA of 10 mM; long-dashed line in C: standard model but with increased mitochondrial
NAD+/NADH ratio of 40. Different colors in panel D represent the four acyl-CoA dehydrogenases; cyan: SCAD, yellow: MCAD, purple: LCAD and green:
VLCAD.
doi:10.1371/journal.pcbi.1003186.g003
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accumulate in the model as well as in the experiment (Figure 2). A
high mitochondrial NAD+/NADH ratio shifts the M/SCHAD
equilibrium in the forward direction, prevents accumulation of the
short-chain intermediates and eventually protects against the
overload phenotype (Figure 3). This provides a functional
explanation for the co-existence of M/SCHAD and Complex I
in a respiratory supercomplex [38,39]: locally, the NADH
produced by M/SCHAD may be kept low by channeling it
directly to complex I. In agreement with this hypothesis, the
respiration-linked b-oxidation rate in gently-disrupted mitochon-
dria (assuming an intact complex between M/SCHAD and
Complex I) was much higher than in completely-disrupted
mitochondria [40].
Besides the protection mechanisms found in the model,
alternative mechanisms might be provided by surrounding
pathways. Limited formation of palmitoyl CoA, either by
inhibition of the synthetase reaction or due to a low cytosolic
CoA concentration, would be very effective. Little is known
however, about regulation of palmitoyl CoA synthesis. Another
option is upregulation of the pathways that consume the product
acetyl CoA, such as the Krebs cycle or the formation of ketone
bodies. Indeed, the liver can produce high amounts of ketone
bodies when confronted with a high fat load [41]. According to the
model, a decreased acetyl-CoA concentration (K1acesink in the
parameter list) should increase the concentration of CoASH
(Table S1), although not as strongly as a decrease of the
mitochondrial NADH concentration.
So far, direct experimental evidence for the overload pheno-
type is lacking. It is not unlikely, however, that it is at the basis of
the well-known association of high FA levels to insulin resistance.
Chronic exposure of muscle to elevated lipid levels results in an
increased expression of FA b-oxidation genes, but this is not
accompanied by an upregulation of downstream metabolic
pathways, such as the TCA cycle and electron transport chain.
In line with our model, it has been reported that this results in
incomplete oxidation of fatty acids and accumulation of acyl
carnitines and ketone bodies (reviewed in [41]). The fact that
CPT1 is required to confer insulin resistance, suggests that the
accumulated intermediate metabolites of the FA b-oxidation
and/or ketone bodies may be involved in insulin resistance [6]. It
is unclear, however, if the CoA esters or the carnitine esters are
responsible for this effect, or both. Administration of L-carnitine,
which is the ‘scavenger’ of CoA esters, sometimes restores glucose
tolerance, in rats as well as humans [7,42]. It is tempting to
speculate that carnitine protects by trans-esterification of CoA
esters to carnitine esters, which liberates CoASH and prevents
accumulation of intermediates. In vivo it is not clear, however, if
carnitine prevents overload, since it plays a dual role: in the
mitochondrial matrix it scavenges intermediate CoA esters, but in
the cytosol it drives the uptake of acyl CoAs into the
mitochondria.
Since glucose and FA oxidation share the mitochondrial
cofactors NAD+/NADH and CoASH, it may be expected that
the presence of glucose will make the b-oxidation even more
susceptible to overload. Vice versa a severe drop in CoASH will also
compromise glucose oxidation via the TCA cycle. To further
understand the interplay between glucose and FA metabolism and
the quantitative role of various protective pathways, it will be of
key interest to link the new model with (partially) existing models
of glucose metabolism, TCA cycle, respiration, ketone-body
synthesis and FA synthesis [43–46]. This should be the next step
in elucidating the mechanisms behind acquired and inborn
diseases of glucose and FA metabolism.
Materials and Methods
Ethics statement
Experimental procedures were approved by the Ethics Com-
mittees for Animal Experiments of the University of Groningen.
Computational methods
The computational model was built and analyzed in Mathe-
matica Wolfram. It consists of a set of Ordinary Differential
Equations (ODEs). Time simulations were done with the
algorithm NDSolve. Steady states were calculated by setting all
time derivatives to zero and solving the resulting set of non-linear
equations with the algorithm FindRoot. FindRoot is a root-finding
algorithm combining damped Newton’s method, the secant
method and Brent’s method. The solutions fulfilled the criterion
that all time derivatives of metabolite concentrations approached
zero (,10211). We have no indications for alternative steady-state
solutions, since different initial conditions led to identical steady
states. As an input for the steady-state root-finding algorithm we
used the endpoint of a time simulation. A Mathematica script and
the corresponding pdf is added to this paper (Protocol S1 (steady
state) and Protocol S2 (time simulation), as well as a detailed model
description in Text S1). The models will become publically
available at JWS Online Cellular Systems Modeling (jjj.bio.vu.nl).
Flux and metabolite concentrations
Mitochondria were isolated from liver tissue of adult female
Wistar rats (250–300 gram) according to Mildaziene [47]. The
oxygen consumption rate of uncoupled mitochondria was
measured with either palmitoyl CoA or palmitoyl carnitine as
substrate, in the presence of ADP at 37uC in a stirred, two-channel
high-resolution Oroboros oxygraph-2 k (Oroboros, Innsbruck,
Austria). All measurements were done in 2 ml of MiR05 medium
[48] to which 0.5 mg/ml mitochondrial protein, 0.2 mM FCCP
(uncoupler), 2 mMmalic acid, 500 mML-carnitine, 1 mMADP and
25 mM of either palmitoyl CoA or palmitoyl carnitine were added.
In parallel, 15–20 ml of the same reaction mixture was analyzed
in a stirred, open vessel from which samples were taken in time for
acyl-carnitine concentrations and TCA-cycle intermediates. Sam-
ples of 1.5 ml each were quenched by adding HCl to a final
concentration of 0.4 M.
Mass spectrometry analysis of acyl carnitines and TCA
cycle intermediates
The determination of the acyl-carnitine concentrations was
done according to Derks et al. [49]. The TCA-cycle intermediates
are measured according to [50].
Supporting Information
Figure S1 Comparison between the model results and
experimental data. Panel A–C: model compared to the data
of the experiment with palmitoyl carnitine as substrate. Error bars
on the experimental data represent SEM (n= 4 for the flux data,
n = 8 for the acyl carnitine concentrations). The reported
experimental flux is 2/3 of the oxygen consumption flux averaged
from 1.5 to 8 min. The modeled flux equals the production fluxes
of NADH plus FADH2 divided by 2 (one O2 oxidizes 2 NADH or
FADH2), averaged over the same time interval. Panel D–G:
Comparison of the flux dynamics over time between model and
experiment with either palmitoyl-CoA or palmitoyl carnitine as
substrate for isolated rat-liver mitochondria. Dashed lines in the
graphs from the experiment represent SEM (n= 4).
(PDF)
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Figure S2 Comparison of the acylcarnitine concentra-
tions between model and experiment. Panel A: palmitoyl
CoA as substrate. Experimental values are depicted at the x-axis
and the model values at the y-axis. Experimental concentration is
the total concentration of intra and extramitochondrial acyl
carnitine. Error bars indicate the SEM of the experimental data
(n= 8). The black line represents a perfect match between the model
and experimental values. Panel B: palmitoylcarnitine as substrate.
Exeperimental values are depicted at the x-axis and the model
values at the y-axis. Experimental concentration is the total con-
centration of intra and extramitochondrial acyl carnitine. Error bars
indicate the SEM of the experimental data (n=8). The black line
represents a perfect match between themodel and experimental values.
(PDF)
Figure S3 Steady-state flux through the FA b-oxidation
(A and C), CoASH concentration (B and D) and con-
centrations of the CoA esters (E–J) from the various
model calculations. Panel A–D: Steady-state flux through the
FA b-oxidation (A and C) and CoASH concentration (B and D) at
various concentrations of the substrate palmitoyl CoA. In the
standard model the malonyl CoA concentration was 0 mM and the
mitochondrial NAD/NADH ratio was 15. Panel E–J: For each
CoA ester the concentrations of the specific CoA esters with
different chain length were summed up. Panel E corresponds to
Figure 3A and B (blue lines) in the main text; Panel F corresponds
to Figure 3A and B (red lines) in the main text; Panel G
corresponds to Figure 3A and B (green lines) in the main text;
Panel H corresponds to Figure 3C (short-dashed lines) in the main
text and Figure S3A and B (long-dashed lines); Panel I corresponds
to Figure S3A and B (short-dashed lines); Panel J corresponds to
Figure 3C (long-dashed lines) in the main text and Figure S3C and
D (short-dashed lines).
(PDF)
Figure S4 Flux distribution through the individual
enzymes for the standard model (black bars) and the
model without competition (white bars) at a palmitoyl-
CoA concentration of 25 mM. This figure corresponds to
Figure 3A and B (blue lines) in the main text.
(PDF)
Protocol S1 Steady-state model of the FA b-oxidation.
(PDF)
Protocol S2 Time-simulationmodel of the FA b-oxidation.
(PDF)
Table S1 Sensitivity analysis of the standard model.
Response coefficients of the concentration of CoASH towards the




approximated by increasing the parameter of interest by 1%.
Response coefficients are ranked from the highest to the lowest
absolute value (positive coefficients in the left-hand column;
negative coefficients in the right-hand column). Response
coefficients were calculated for the steady-state standard model
with 25 mM palmitoyl CoA as substrate.
(PDF)
Text S1 Model description.
(PDF)
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